Header Logo

Connection

Mandisa Singata-Madliki to Humans

Back to Details
This is a "connection" page, showing publications Mandisa Singata-Madliki has written about Humans.
Mandisa Singata-Madliki
Connection Strength
0,934
Humans
  1. Improving management of first and second stages of labour in low- and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2024 Jul; 95:102517.
    View in: PubMed
    Score: 0,073
  2. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
    View in: PubMed
    Score: 0,072
  3. Implementing E-MOTIVE for detection and treatment of postpartum haemorrhage in South Africa. S Afr Med J. 2023 Dec 04; 113(12):24.
    View in: PubMed
    Score: 0,070
  4. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
    View in: PubMed
    Score: 0,060
  5. A novel, re-usable 'Safe birth Tray' for postpartum blood loss monitoring: A preliminary acceptability assessment. Int J Gynaecol Obstet. 2021 Dec; 155(3):553-555.
    View in: PubMed
    Score: 0,060
  6. Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial. Int J Gynaecol Obstet. 2021 Aug; 154(2):256-262.
    View in: PubMed
    Score: 0,058
  7. The second stage of labor. Best Pract Res Clin Obstet Gynaecol. 2020 Aug; 67:53-64.
    View in: PubMed
    Score: 0,054
  8. Novel suction tube uterine tamponade for treating intractable postpartum haemorrhage: description of technique and report of three cases. BJOG. 2020 09; 127(10):1280-1283.
    View in: PubMed
    Score: 0,054
  9. Randomized feasibility study of suction-tube uterine tamponade for postpartum hemorrhage. Int J Gynaecol Obstet. 2019 Sep; 146(3):339-343.
    View in: PubMed
    Score: 0,052
  10. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. BMJ Open. 2017 Nov 12; 7(11):e019205.
    View in: PubMed
    Score: 0,046
  11. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
    View in: PubMed
    Score: 0,018
  12. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
    View in: PubMed
    Score: 0,018
  13. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
    View in: PubMed
    Score: 0,018
  14. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
    View in: PubMed
    Score: 0,018
  15. Calcium supplementation to prevent pre-eclampsia: protocol for an individual participant data meta-analysis, network meta-analysis and health economic evaluation. BMJ Open. 2023 05 11; 13(5):e065538.
    View in: PubMed
    Score: 0,017
  16. Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage. N Engl J Med. 2023 Jul 06; 389(1):11-21.
    View in: PubMed
    Score: 0,017
  17. Factors influencing postpartum haemorrhage detection and management and the implementation of a new postpartum haemorrhage care bundle (E-MOTIVE) in Kenya, Nigeria, and South Africa. Implement Sci. 2023 01 11; 18(1):1.
    View in: PubMed
    Score: 0,016
  18. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. J Acquir Immune Defic Syndr. 2022 09 01; 91(1):26-30.
    View in: PubMed
    Score: 0,016
  19. Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania. Int J Gynaecol Obstet. 2022 Jun; 158 Suppl 1:46-55.
    View in: PubMed
    Score: 0,016
  20. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
    View in: PubMed
    Score: 0,016
  21. Cumulative incidence of SARS-CoV-2 and associated risk factors among healthcare workers: a cross-sectional study in the Eastern Cape, South Africa. BMJ Open. 2022 03 18; 12(3):e058761.
    View in: PubMed
    Score: 0,016
  22. Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women and babies at term. Cochrane Database Syst Rev. 2022 03 04; 3:CD010088.
    View in: PubMed
    Score: 0,016
  23. Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life. Sci Rep. 2021 02 04; 11(1):3173.
    View in: PubMed
    Score: 0,014
  24. Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol. Int J Environ Res Public Health. 2021 01 05; 18(1).
    View in: PubMed
    Score: 0,014
  25. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 08 14; 71(4):1030-1039.
    View in: PubMed
    Score: 0,014
  26. A new plan for extended paediatric HIV testing is needed in Africa. Lancet Glob Health. 2019 12; 7(12):e1603-e1604.
    View in: PubMed
    Score: 0,013
  27. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Lancet HIV. 2019 05; 6(5):e307-e314.
    View in: PubMed
    Score: 0,013
  28. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019 01 26; 393(10169):330-339.
    View in: PubMed
    Score: 0,013
  29. HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study. BMJ Open. 2018 04 05; 8(4):e019239.
    View in: PubMed
    Score: 0,012
  30. Participant recruitment and retention in longitudinal preconception randomized trials: lessons learnt from the Calcium And Pre-eclampsia (CAP) trial. Trials. 2017 Oct 26; 18(1):500.
    View in: PubMed
    Score: 0,011
  31. Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Transmission during Breastfeeding. Antimicrob Agents Chemother. 2017 02; 61(2).
    View in: PubMed
    Score: 0,011
  32. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
    View in: PubMed
    Score: 0,010
  33. Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014 Dec; 90(6):615-6.
    View in: PubMed
    Score: 0,009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.